India: Credit Control and Cashflow

To promote good corporate governance and enhance disclosure requirement in Related Party Transactions (RPTs), SEBI vide Circular dated February 14, 2025 issued Industry Standards...

We conducted 209th webinar on "Industry Standards on Minimum Information to be Provided for Approval of RPT" on 21st February, 2025. Click here to view the recording...

The Securities Exchange Board of India ("SEBI") by Circular No. SEBI/HO/MRD/TPD/CIR/P/2025/50 dated 04.04.2025 ("Circular") has prescribed the standardized format for System and Network audit report of Market Infrastructure Institutions ("MIIs").

Ministry of Corporate Affairs ("MCA") vide notification no. G.S.R. 291 (E) dated 7th May, 2025 made amendments in the Companies (Indian Accounting Standards) Rules, 2015.

CFOs today frequently face questions about digital transformation. Digital transformation in finance and accounting offers mid-size companies the promise of enhanced efficiency, accuracy, and strategic decision-making.

We conducted 209th webinar on "Industry Standards on Minimum Information to be Provided for Approval of RPT" on 21st February, 2025. Click here to view the recording...

Legislation should be amended, if necessary, to ensure MNEs do not face undue hardship.

The threshold level of income exempt from tax is proposed to be raised from Rs: 50,000 to Rs: 1,00,000. The threshold level for women who have not attained the age of 65 is proposed at Rs: 1,25,000. This replaces the rebate allowable to women u/s 88 – C which now stands eliminated. The threshold level for senior citizens is proposed at Rs: 1,50,000. This replaces the rebate allowable to senior citizens u/s 88 – B which now stands eliminated

Novelty is one of the basic criteria of patentability, inventiveness and industrial applicability being the other two. If the use of a substance or a composition for a specified medical purpose is new, a claim in a patent application directed at this use will be considered as novel even if the same substance had previously been used in medicine for a different purpose.